RSPO2 and hepatocellular carcinoma: High levels of RSPO2 are detected in these tumours, whilst immunohistochemical analysis of HCC tumours harbouring RSPO2 mutations showed both strong nuclear β-catenin and glutamine synthetase staining, indicating a strong WNT pathway activation in these tumours [53].